294 related articles for article (PubMed ID: 27013187)
1. Expression of Apoptosis-regulating Proteins Bcl-2 and Bax in Lymph Node Aspirates from Dogs with Lymphoma.
Meichner K; Fogle JE; English L; Suter SE
J Vet Intern Med; 2016 May; 30(3):819-26. PubMed ID: 27013187
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric characterization and clinical outcome of CD4+ T-cell lymphoma in dogs: 67 cases.
Avery PR; Burton J; Bromberek JL; Seelig DM; Elmslie R; Correa S; Ehrhart EJ; Morley PS; Avery AC
J Vet Intern Med; 2014; 28(2):538-46. PubMed ID: 24495161
[TBL] [Abstract][Full Text] [Related]
3. Checkpoint molecule expression by B and T cell lymphomas in dogs.
Hartley G; Elmslie R; Dow S; Guth A
Vet Comp Oncol; 2018 Sep; 16(3):352-360. PubMed ID: 29380929
[TBL] [Abstract][Full Text] [Related]
4. The role of the multi-drug resistance 1, p53, b cell lymphoma 2, and bcl 2-associated X genes in the biologic behavior and chemotherapeutic resistance of canine transmissible venereal tumors.
Alzate JM; Montoya-Florez LM; Pérez JE; Rocha NS; Pedraza-Ordonez FJ
Vet Clin Pathol; 2019 Dec; 48(4):730-739. PubMed ID: 31777108
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological characteristics and prognostic factors for canine multicentric non-indolent T-cell lymphoma: 107 cases.
Purzycka K; Peters LM; Desmas I; Davies O; Chang YM; Lara-Garcia A
Vet Comp Oncol; 2020 Dec; 18(4):656-663. PubMed ID: 32163214
[TBL] [Abstract][Full Text] [Related]
6. Specific immunotypes of canine T cell lymphoma are associated with different outcomes.
Deravi N; Berke O; Woods JP; Bienzle D
Vet Immunol Immunopathol; 2017 Sep; 191():5-13. PubMed ID: 28895866
[TBL] [Abstract][Full Text] [Related]
7. Clinical features of canine nodal T-cell lymphomas classified as CD8+ or CD4-CD8- by flow cytometry.
Harris LJ; Rout ED; Labadie JD; Avery PR; Fernandez M; Yoshimoto J; Avery AC
Vet Comp Oncol; 2020 Sep; 18(3):416-427. PubMed ID: 31951040
[TBL] [Abstract][Full Text] [Related]
8. Treatment of T cell lymphoma in dogs.
Moore AS
Vet Rec; 2016 Sep; 179(11):277. PubMed ID: 27634860
[TBL] [Abstract][Full Text] [Related]
9. Canine CD4+ T-cell lymphoma identified by flow cytometry exhibits a consistent histomorphology and gene expression profile.
Harris LJ; Hughes KL; Ehrhart EJ; Labadie JD; Yoshimoto J; Avery AC
Vet Comp Oncol; 2019 Sep; 17(3):253-264. PubMed ID: 30684308
[TBL] [Abstract][Full Text] [Related]
10. Soy-derived isoflavones inhibit the growth of canine lymphoid cell lines.
Jamadar-Shroff V; Papich MG; Suter SE
Clin Cancer Res; 2009 Feb; 15(4):1269-76. PubMed ID: 19228730
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric evaluation of ki67 for the determination of malignancy grade in canine lymphoma.
Poggi A; Miniscalco B; Morello E; Comazzi S; Gelain ME; Aresu L; Riondato F
Vet Comp Oncol; 2015 Dec; 13(4):475-80. PubMed ID: 24341365
[TBL] [Abstract][Full Text] [Related]
12. Canine T-zone lymphoma: unique immunophenotypic features, outcome, and population characteristics.
Seelig DM; Avery P; Webb T; Yoshimoto J; Bromberek J; Ehrhart EJ; Avery AC
J Vet Intern Med; 2014; 28(3):878-86. PubMed ID: 24655022
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA profiling in canine multicentric lymphoma.
Craig KKL; Wood GA; Keller SM; Mutsaers AJ; Wood RD
PLoS One; 2019; 14(12):e0226357. PubMed ID: 31826004
[TBL] [Abstract][Full Text] [Related]
14. Comparison of serum cytokine levels between dogs with multicentric lymphoma and healthy dogs.
Calvalido J; Wood GA; Mutsaers AJ; Wood D; Sears W; Woods JP
Vet Immunol Immunopathol; 2016 Dec; 182():106-114. PubMed ID: 27863540
[TBL] [Abstract][Full Text] [Related]
15. Proliferative and apoptotic changes in the healthy canine endometrium and in cystic endometrial hyperplasia.
Reusche N; Beineke A; Urhausen C; Beyerbach M; Schmicke M; Kramer S; Günzel-Apel AR
Theriogenology; 2018 Jul; 114():14-24. PubMed ID: 29574305
[TBL] [Abstract][Full Text] [Related]
16. Response rate after administration of a single dose of doxorubicin in dogs with B-cell or T-cell lymphoma: 41 cases (2006-2008).
Beaver LM; Strottner G; Klein MK
J Am Vet Med Assoc; 2010 Nov; 237(9):1052-5. PubMed ID: 21034344
[TBL] [Abstract][Full Text] [Related]
17. Loss of CD45 cell surface expression in canine T-zone lymphoma results from reduced gene expression.
Martini V; Cozzi M; Aricò A; Dalla Rovere G; Poggi A; Albonico F; Mortarino M; Ciusani E; Aresu L; Comazzi S
Vet Immunol Immunopathol; 2017 May; 187():14-19. PubMed ID: 28494924
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of single-agent mitoxantrone as chemotherapy for relapsing canine lymphoma.
Lucroy MD; Phillips BS; Kraegel SA; Simonson ER; Madewell BR
J Vet Intern Med; 1998; 12(5):325-9. PubMed ID: 9773407
[TBL] [Abstract][Full Text] [Related]
19. Bcl-2 and bax protein expression in indolent versus aggressive B-cell non-Hodgkin's lymphomas.
Wheaton S; Netser J; Guinee D; Rahn M; Perkins S
Hum Pathol; 1998 Aug; 29(8):820-5. PubMed ID: 9712423
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome and Ki67 evaluation in dogs with nodal small cell B-cell lymphoma diagnosed by flow cytometry.
Rout ED; Fernandez M; Yoshimoto JA; Hughes KL; Avery AC; Burton JH
J Vet Intern Med; 2022 Sep; 36(5):1770-1781. PubMed ID: 35996942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
